Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2013-01-08 Share Issue/Capital Cha…
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Generix Group : Déclaration de droits de vote et d'actions au 31 décembre 2012
Share Issue/Capital Change Classification · 95% confidence The document is dated January 8, 2013, and explicitly references French regulatory articles (L. 233-8 II du Code de Commerce and article 223-16 du règlement général de l'Autorité des Marchés Financiers - AMF). It presents a table detailing the 'Nombre total de droits de vote et d'actions' (Total number of voting rights and shares) as of December 31, 2012. This type of mandatory disclosure regarding the total share capital and voting rights structure is a specific regulatory filing requirement, often related to capital structure updates or general corporate information, but it does not fit perfectly into the primary categories like 10-K, ER, or DIV. Given the specific nature of reporting total voting rights, it is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure that doesn't align with the more specific financial or meeting-related codes provided, although it is a very specific type of regulatory notice.
2013-01-08 French
Generix Group announces its interim results for the six- month period ended September 30, 2012
Earnings Release Classification · 99% confidence The document explicitly states it contains the company's 'interim financial statements for the six-month period ended September 30, 2012' and presents detailed financial tables for the 'Six months ended September 30'. This content aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it mentions the 'Half-Year Financial Report' is available for download at the end, the provided text itself contains the core financial data and management commentary typical of the report, rather than just being a short announcement about its publication (which would suggest RPA or RNS). Therefore, the classification should be IR. H1 2013
2012-11-26 English
Generix Group annonce ses résultats pour son premier semestre de l'exercice 2012/2013
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the first half (S1) of the 2012/2013 fiscal year. It provides key financial highlights, tables, and commentary on performance, but explicitly states at the end that the full 'Rapport Financier semestriel' (Interim Report) is available for download via a link. Because the document is a summary announcement of results rather than the full statutory report itself, it is classified as an Earnings Release (ER). H1 2012
2012-11-26 French
Generix Group : Rapport financier semestriel au 30 septembre 2012
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier Semestriel' (Semi-annual Financial Report) for Generix Group for the period ending September 30, 2012. It contains comprehensive financial statements (IFRS consolidated statements), management activity reports, notes to the financial statements, and audit reports. Since it covers a period shorter than a full fiscal year and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2012
2012-11-26 French
Generix Group : Déclaration de droits de vote et d'actions au 31 octobre 2012
Regulatory Filings Classification · 95% confidence The document is dated November 9, 2012, and explicitly references Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. It presents a table showing the total number of shares and theoretical voting rights as of October 31, 2012. This structure is characteristic of a mandatory regulatory disclosure regarding the total number of voting rights, which often falls under general regulatory announcements or specific share/capital change disclosures. Since it is a formal disclosure of voting rights structure rather than a director's trade (DIRS) or a declaration of specific vote results (DVA), and given the context of mandatory regulatory reporting, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard disclosure, or potentially 'SHA' if interpreted as a capital structure update, but RNS is safer for general regulatory compliance notices not covered elsewhere. Given the focus on 'droits de vote' (voting rights) and the short format, RNS is the most appropriate fallback for this specific regulatory notice.
2012-11-09 French
Generix Group : Q2 Revenue 2012/2013: €14.8 M Growth in Software activities - EBITDA up significantly
Earnings Release Classification · 98% confidence The document explicitly states it 'today issued its revenues for the second quarter, ended September 30, 2012, of its financial year 2012/2013.' It presents key financial highlights, including revenue tables broken down by Licenses, Maintenance, SaaS, and Consulting Services, and mentions EBITDA performance. This structure—a press release format focusing on period-specific financial results (Q2)—is characteristic of an Earnings Release (ER). It is not the comprehensive annual report (10-K) or the detailed interim report (IR), but rather the initial announcement of the results. Q2 2013
2012-10-22 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.